BRIUMVI
TG Therapeutics Partners with Neuraxpharm to Launch Game-Changing Multiple Sclerosis Antibody Briumvi Worldwide
SG Tylor
After gaining approval for Briumvi in the US eight months ago, TG Therapeutics is now set to introduce its multiple ...
BRIUMVI Receives Green Light from European Commission as Treatment for Relapsing Multiple Sclerosis
SG Tylor
The European Commission (EC) gave the green light for the use of TG Therapeutics‘ BRIUMVI (ublituximab-xiiy) to treat relapsing forms ...
